Hasmukh Chudgar & family

Hasmukh Chudgar, a self-made billionaire, is the founder of Intas Pharmaceuticals, a global pharmaceutical company. With a current net worth of $7.6 billion, he has built a legacy in the healthcare industry. Chudgar's career, spanning over five decades, began with a pharmacy degree from Gujarat University, leading to the establishment of Intas Pharmaceuticals in 1977. His achievements include launching Eleftha, an affordable drug to treat breast cancer. The Chudgar family continues to lead Intas, with his sons Binish, Nimish, and Urmish now managing the company. Intas Pharmaceuticals is recognized for its focus on high-barrier generics and biosimilars, exporting products to over 85 countries.

The Full Dossier

Early Life

Hasmukh Chudgar was born in India and pursued a Bachelor of Pharmacy from Gujarat University. Graduating in 1954, he began his journey in the pharmaceutical industry.

Rise to Success

In 1977, Hasmukh Chudgar founded Intas Pharmaceuticals in Ahmedabad, India. Starting as a generics manufacturer, the company grew under his leadership, expanding its operations and product portfolio.

Key Business Strategies

Intas Pharmaceuticals focused on vertical integration and strategic acquisitions to enhance its market position. The acquisition of Actavis UK and Actavis Ireland in 2016 for $764 million was a key move. The company has expanded its global presence, with a strong focus on high-value generics and biosimilars. Chudgar's approach involved maintaining a low profile while ensuring the company's growth through strategic decisions and family leadership.

Philanthropy

Hasmukh Chudgar is known for his commitment to simplicity and entrepreneurial values. He is a trustee of Intas Welfare Trust, which supports the company's employees. While specific philanthropy amounts are not available, his actions reflect a dedication to employee welfare.

Career Timeline

2019

Launched Eleftha

Launched Eleftha, an affordable drug to treat breast cancer.

2016

Acquired Actavis UK and Actavis Ireland

Guided Intas in the acquisition of Actavis UK and Actavis Ireland from Teva Pharmaceuticals.

1977

Founded Intas Pharmaceuticals

Established Intas Pharmaceuticals in Ahmedabad, India, focusing on generic drugs.